People with diabetes and depression who take antidepressants may have a lower risk of death and of serious diabetes complications, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. People with diabetes face a higher risk of depression, which makes them more likely to die or develop diabetes complications...
Readmitted patients have two times the death rate during a second hospitalization with diabetic ketoacidosis, so providers should identify factors predisposing them to a second DKA episode, according to a study presented at ENDO 2021. In “Rates and Predictors of 30-Day Readmission in Adults with Type 1 Diabetes Hospitalized for Diabetic Ketoacidosis in the US:...
Consuming a sardine-enriched diet may prevent the development of type 2 diabetes, according to a study recently published in Clinical Nutrition. Researchers led by Diana A. Diaz-Rizzolo, PhD, of the Open University of Catalonia in Barcelona, Spain, point out that consuming fish could play a role in preventing diabetes, but the specific types of fish...
Since the first, all-virtual ENDO 2021 stemmed from the lingering effects of the COVID-19 pandemic, Endocrine News presents an overview of the research that specifically addressed how the virus affects patients with common comorbidities. These studies looked at COVID-19’s effects on patients with obesity, hyperglycemia, adrenal insufficiency, and a lack of vitamin D, and provide...
Two recent papers touted the benefits of having an endocrine hospitalist-led Inpatient Diabetes Management Service (IDMS) in a community hospital setting to reduce the rates of both hypoglycemia and hyperglycemia, length of stay, and even hospital costs. Endocrine News gets a firsthand look at a community hospital’s use of an IDMS from both endocrinologists and...
A new study finds people who consume two servings of fruit per day have 36% lower odds of developing type 2 diabetes than those who consume less than half a serving. The research was published in the The Journal of Clinical Endocrinology & Metabolism. Diabetes is a disease where people have too much sugar in...
Drawing on years of prior research, a new paper published recently in The Journal of Clinical Endocrinology & Metabolism makes the case for a wider classification of a complex disease such as type 2 diabetes. A new series of subsets would take into account race, age at onset, and a host of other contributing factors....
Earlier this week Diabetes Care published results from a Phase 3 trial evaluating dasiglucagon for the treatment of severe hypoglycemia in adults with diabetes. Zealand Pharma is marketing the drug as Zegalogue. The study found that dasiglucagon administration resulted in a reversal of hypoglycemia (with a median recovery time of 10 minutes) with 99% of...
Since the first, all-virtual ENDO 2021 stemmed from the lingering effects of the COVID-19 pandemic, Endocrine News presents an overview of the research that specifically addressed how the virus affects patients with common comorbidities. These studies looked at COVID-19’s effects on patients with obesity, hyperglycemia, adrenal insufficiency, and a lack of vitamin D, and provide...
Two recent papers touted the benefits of having an endocrine hospitalist-led Inpatient Diabetes Management Service (IDMS) in a community hospital setting to reduce the rates of both hypoglycemia and hyperglycemia, length of stay, and even hospital costs. Endocrine News gets a firsthand look at a community hospital’s use of an IDMS from both endocrinologists and...
